NeuroPace, Inc. designs, develops, manufactures, and markets implantable devices for the treatment of neurological disorders. It offers responsive Neurostimulator system (RNS) for the treatment of medically refractory partial epilepsy. The company's RNS system consists of implantable components, including RNS neurostimulator that delivers a short train of electrical pulses to the brain, and depth leads and cortical strip leads; and external products, such as the programmer, a laptop computer with proprietary software that has a wand and telemetry interface enabling communication with an implanted RNS neurostimulator.
NeuroPace, Inc. was incorporated in 1997 and is based in Mountain View, California.
Funding Rounds (3) - $67MUpdate
Current Team (10)Update
Board Members and Advisors (2)Update
|Jun 16, 2016||Business Insider Australia - Part of the Warriors training involves controversial brain-zapping headphones|
|Jun 15, 2016||Business Insider (tech) - Part of the Warriors' training involves controversial brain-zapping headphones|
|May 9, 2016||TechCrunch - Halo is building a wearable to make athletes better, stronger, faster|
|Apr 28, 2016||PRNewswire UK All - Deep Brain Stimulation Market: 10.59% CAGR, Worth $906B by 2020|
|Apr 27, 2016||Read Write - Can Halo Sport change our brain efficiency?1|
|Feb 11, 2016||Med City News - Halo Neuroscience CEO talks about its dual approach to the neurostimulation market|
|Feb 2, 2016||Mass Device - Medtech approvals: FDA releases December 2015 PMAs|
|Dec 28, 2015||PRNewswire All - Global Neurostimulation Devices Market is Expected to Grow With 13% CAGR During 2015 - 2020: P&S Market Research|
455 N. Bernardo Avenue
Mountain View, CA 94043